Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-009899

President and CEO sold 21,000 shares at $15.16 ($318,360)

  • President and CEO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Grossman Adam S President and CEO 2026-03-16 Option exercise 10b5-1 +15,000 $5.40 $81,000 2,133,777 D: show line 1 in the form
Grossman Adam S President and CEO 2026-03-16 Sale 10b5-1 −15,000 $15.16 $227,400 2,118,777 D: show line 2 in the form
Grossman Adam S President and CEO 2026-03-16 Sale 10b5-1 −6,000 $15.16 $90,960 2,112,777 D: show line 3 in the form
Open-market sales · 21,000 sh · avg $15.16 · $318,360

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Grossman Adam S President and CEO 2026-03-16 Option exercise · Stock Option (right to buy) 10b5-1 −15,000 690,950 D: show line 4 in the form
Loading xslF345X05/form4.xml…